SeraCare, Toma Bio Forge Codevelopment Partnership | GenomeWeb

NEW YORK (GenomeWeb) – SeraCare Life Sciences and Toma Biosciences announced today that they are entering into a codevelopment partnership.

Terms of the agreement call for SeraCare to provide Toma with access to its Seraseq Solid Tumor Mutation mix reference material technology to support the development and validation of Toma OS-Seq, a comprehensive solid tumor gene analysis kit, and Toma's upcoming PlasmaSeq liquid biopsy test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.